* BIO-Key International Inc BKYI.OQ reported a quarterly
adjusted loss of 21 cents per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 8 cents per share.
* Revenue rose 96.3% to $1.95 million from a year ago;
analysts
expected $2.50 million.
* The mean earnings estimate of analysts had fallen by
about 33.3%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* BIO-Key International Inc shares had risen by 22.6% this
quarter and lost 1.8% so far this year.
* The company reported a quarterly loss of $1.72 million.
* Wall Street's median 12-month price target for BIO-Key
International Inc is $5.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data August 12
at 01:31 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 -0.08 -0.21 Missed
Mar. 31 2022 -0.22 -0.12 Beat
Dec. 31 2021 -0.15 -0.26 Missed
Sep. 30 2021 -0.11 -0.13 Missed